|
US4797368A
(en)
|
1985-03-15 |
1989-01-10 |
The United States Of America As Represented By The Department Of Health And Human Services |
Adeno-associated virus as eukaryotic expression vector
|
|
US4683202A
(en)
|
1985-03-28 |
1987-07-28 |
Cetus Corporation |
Process for amplifying nucleic acid sequences
|
|
US4683195A
(en)
|
1986-01-30 |
1987-07-28 |
Cetus Corporation |
Process for amplifying, detecting, and/or-cloning nucleic acid sequences
|
|
US5139941A
(en)
|
1985-10-31 |
1992-08-18 |
University Of Florida Research Foundation, Inc. |
AAV transduction vectors
|
|
US4962091A
(en)
|
1986-05-23 |
1990-10-09 |
Syntex (U.S.A.) Inc. |
Controlled release of macromolecular polypeptides
|
|
US7070994B2
(en)
|
1988-03-21 |
2006-07-04 |
Oxford Biomedica (Uk) Ltd. |
Packaging cells
|
|
US5591624A
(en)
|
1988-03-21 |
1997-01-07 |
Chiron Viagene, Inc. |
Retroviral packaging cell lines
|
|
CA1339354C
(en)
|
1988-09-01 |
1997-08-26 |
The Whitehead Institute For Biomedical Research |
Recombinant retroviruses with amphotropic and ecotropic host ranges
|
|
US5585362A
(en)
|
1989-08-22 |
1996-12-17 |
The Regents Of The University Of Michigan |
Adenovirus vectors for gene therapy
|
|
US5817491A
(en)
|
1990-09-21 |
1998-10-06 |
The Regents Of The University Of California |
VSV G pseusdotyped retroviral vectors
|
|
JP3534749B2
(ja)
|
1991-08-20 |
2004-06-07 |
アメリカ合衆国 |
アデノウイルスが介在する胃腸管への遺伝子の輸送
|
|
US5252479A
(en)
|
1991-11-08 |
1993-10-12 |
Research Corporation Technologies, Inc. |
Safe vector for gene therapy
|
|
FR2688514A1
(fr)
|
1992-03-16 |
1993-09-17 |
Centre Nat Rech Scient |
Adenovirus recombinants defectifs exprimant des cytokines et medicaments antitumoraux les contenant.
|
|
DE4228457A1
(de)
|
1992-08-27 |
1994-04-28 |
Beiersdorf Ag |
Herstellung von heterodimerem PDGF-AB mit Hilfe eines bicistronischen Vektorsystems in Säugerzellen
|
|
CA2145093C
(en)
|
1992-09-25 |
2007-04-10 |
Lawrence Leroy Kunz |
Therapeutic inhibitor of vascular smooth muscle cells
|
|
AU680459B2
(en)
|
1992-12-03 |
1997-07-31 |
Genzyme Corporation |
Gene therapy for cystic fibrosis
|
|
US5834256A
(en)
|
1993-06-11 |
1998-11-10 |
Cell Genesys, Inc. |
Method for production of high titer virus and high efficiency retroviral mediated transduction of mammalian cells
|
|
ES2249761T3
(es)
|
1993-06-24 |
2006-04-01 |
Advec Inc. |
Vectores de adenovirus para terapia genica.
|
|
EP1637608B1
(en)
|
1993-10-25 |
2009-07-22 |
CANJI, Inc. |
Recombinant adenoviral vector and methods of use
|
|
PT728214E
(pt)
|
1993-11-09 |
2004-11-30 |
Ohio Med College |
Linhas celulares estaveis capazes de expressar o gene de replicacao do virus adeno-associado
|
|
FR2722208B1
(fr)
|
1994-07-05 |
1996-10-04 |
Inst Nat Sante Rech Med |
Nouveau site interne d'entree des ribosomes, vecteur le contenant et utilisation therapeutique
|
|
US6013516A
(en)
|
1995-10-06 |
2000-01-11 |
The Salk Institute For Biological Studies |
Vector and method of use for nucleic acid delivery to non-dividing cells
|
|
US5928906A
(en)
|
1996-05-09 |
1999-07-27 |
Sequenom, Inc. |
Process for direct sequencing during template amplification
|
|
FR2751345B1
(fr)
|
1996-07-16 |
1998-09-18 |
Univ Paris Curie |
Lignees d'encapsidation hautement productrices
|
|
CA2265460A1
(en)
|
1996-09-11 |
1998-03-19 |
The Government Of The United States Of America, Represented By The Secre Tary, Department Of Health And Human Services |
Aav4 vector and uses thereof
|
|
US6306434B1
(en)
|
1997-02-12 |
2001-10-23 |
Chong Kun Dang Corp. |
Pharmaceutical composition comprising cyclosporin solid-state microemulsion
|
|
US6156303A
(en)
|
1997-06-11 |
2000-12-05 |
University Of Washington |
Adeno-associated virus (AAV) isolates and AAV vectors derived therefrom
|
|
US5994136A
(en)
|
1997-12-12 |
1999-11-30 |
Cell Genesys, Inc. |
Method and means for producing high titer, safe, recombinant lentivirus vectors
|
|
EP1082413B1
(en)
|
1998-05-28 |
2008-07-23 |
THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES |
Aav5 vector and uses thereof
|
|
US6984517B1
(en)
|
1998-05-28 |
2006-01-10 |
The United States Of America As Represented By The Department Of Health And Human Services |
AAV5 vector and uses thereof
|
|
CA2349838C
(en)
|
1998-11-05 |
2011-06-07 |
The Trustees Of The University Of Pennsylvania |
Adeno-associated virus serotype 1 nucleic acid sequences, vectors and host cells containing same
|
|
US6759237B1
(en)
|
1998-11-05 |
2004-07-06 |
The Trustees Of The University Of Pennsylvania |
Adeno-associated virus serotype 1 nucleic acid sequences, vectors and host cells containing same
|
|
JP3904451B2
(ja)
|
1999-06-01 |
2007-04-11 |
俊雄 北村 |
パッケージング細胞
|
|
PT1916258E
(pt)
|
1999-08-09 |
2014-07-29 |
Genzyme Corp |
Aumento da expressão de uma sequência nucleotídica heteróloga de cadeia simples a partir de vectores virais recombinantes por concepção da sequência de maneira que esta forme pares de bases intracadeia
|
|
CA2406743A1
(en)
|
2000-04-28 |
2001-11-08 |
The Trustees Of The University Of Pennsylvania |
Recombinant aav vectors with aav5 capsids and aav5 vectors pseudotyped in heterologous capsids
|
|
NZ522840A
(en)
|
2000-06-01 |
2004-12-24 |
Univ North Carolina |
A parvovirus vector that carries a duplexed genome resulting in co-packaging of strands of plus and minus polarity tethered together
|
|
ATE324321T1
(de)
|
2000-08-31 |
2006-05-15 |
Edwin Lundgren |
Steuervorrichtung für einen lenkdrachen an einem boot
|
|
AU2002248297A1
(en)
|
2001-01-05 |
2002-07-16 |
Children's Hospital, Inc. |
Aav2 vectors and methods
|
|
WO2002098432A1
(en)
|
2001-06-01 |
2002-12-12 |
The Brigham And Women's Hospital, Inc. |
Methods of treating cardiac disorders
|
|
WO2003042361A2
(en)
|
2001-11-09 |
2003-05-22 |
Government Of The United States Of America, Department Of Health And Human Services |
Production of adeno-associated virus in insect cells
|
|
NZ532635A
(en)
|
2001-11-13 |
2007-05-31 |
Univ Pennsylvania |
A method of identifying unknown adeno-associated virus (AAV) sequences and a kit for the method
|
|
AU2002359284A1
(en)
|
2001-12-17 |
2003-06-30 |
The Trustees Of The University Of Pennsylvania |
Adeno-associated virus (aav) serotype 9 sequences, vectors containing same, and uses therefor
|
|
DK2359869T3
(en)
|
2001-12-17 |
2019-04-15 |
Univ Pennsylvania |
Sequences of adeno-associated virus (AAV) serotype 8, vectors containing these, and uses thereof
|
|
US7091029B2
(en)
|
2002-09-23 |
2006-08-15 |
Applied Genetics Technologies Corporation |
High titer recombinant AAV production
|
|
US7485291B2
(en)
|
2003-06-03 |
2009-02-03 |
Cell Genesys, Inc. |
Compositions and methods for generating multiple polypeptides from a single vector using a virus derived peptide cleavage site, and uses thereof
|
|
SI3235827T1
(sl)
|
2003-06-19 |
2021-05-31 |
Genzyme Corporation |
AAV virioni z zmanjšano imunoreaktivnostjo in uporaba za ta namen
|
|
US9441244B2
(en)
|
2003-06-30 |
2016-09-13 |
The Regents Of The University Of California |
Mutant adeno-associated virus virions and methods of use thereof
|
|
US9233131B2
(en)
|
2003-06-30 |
2016-01-12 |
The Regents Of The University Of California |
Mutant adeno-associated virus virions and methods of use thereof
|
|
CN1856576B
(zh)
|
2003-09-30 |
2011-05-04 |
宾夕法尼亚州立大学托管会 |
腺伴随病毒(aav)进化支、序列、含有这些序列的载体及它们的应用
|
|
US7960100B1
(en)
|
2004-04-30 |
2011-06-14 |
Celera Corporation |
Colon cancer targets and uses thereof
|
|
FR2872170B1
(fr)
|
2004-06-25 |
2006-11-10 |
Centre Nat Rech Scient Cnrse |
Lentivirus non interactif et non replicatif, preparation et utilisations
|
|
WO2006110689A2
(en)
|
2005-04-07 |
2006-10-19 |
The Trustees Of The University Of Pennsylvania |
Method of increasing the function of an aav vector
|
|
WO2007078599A2
(en)
|
2005-12-16 |
2007-07-12 |
The Board Of Trustees Of The Leland Stanford Junior University |
Functional arrays for high throughput characterization of gene expression regulatory elements
|
|
US20070161031A1
(en)
|
2005-12-16 |
2007-07-12 |
The Board Of Trustees Of The Leland Stanford Junior University |
Functional arrays for high throughput characterization of gene expression regulatory elements
|
|
US7867484B2
(en)
|
2006-01-27 |
2011-01-11 |
University Of North Carolina At Chapel Hill |
Heparin and heparan sulfate binding chimeric vectors
|
|
WO2008016391A2
(en)
|
2006-01-31 |
2008-02-07 |
The Board Of Trustees Of The Leland Stanford Junior University |
Self-complementary parvoviral vectors, and methods for making and using the same
|
|
EP2520935A3
(en)
|
2006-08-09 |
2013-02-13 |
Homestead Clinical Corporation |
Organ-specific proteins and methods of their use
|
|
ES2385679T3
(es)
|
2006-08-24 |
2012-07-30 |
Virovek, Inc. |
Expresión de células de insecto de genes con marcos de lectura abiertos superpuestos, métodos y composiciones de éstos
|
|
EP3257937B1
(en)
|
2008-02-19 |
2022-08-03 |
uniQure IP B.V. |
Optimisation of expression of parvoviral rep and cap proteins in insect cells
|
|
WO2009126894A2
(en)
|
2008-04-11 |
2009-10-15 |
Massachusetts Eye And Ear Infirmary |
Methods and compositions for the diagnosis and treatment of angiogenic disorders
|
|
US8679837B2
(en)
|
2009-04-02 |
2014-03-25 |
University Of Florida Research Foundation, Inc. |
Inducible system for highly efficient production of recombinant Adeno-associated virus (rAAV) vectors
|
|
JP5879256B2
(ja)
|
2009-05-02 |
2016-03-08 |
ジェンザイム・コーポレーション |
神経変性障害のための遺伝子治療
|
|
EP2292781A1
(en)
|
2009-08-17 |
2011-03-09 |
Genethon |
Baculovirus-based production of biopharmaceuticals free of contaminating baculoviral virions
|
|
ES2683695T3
(es)
|
2010-01-12 |
2018-09-27 |
The University Of North Carolina At Chapel Hill |
Repeticiones terminales invertidas restrictivas para vectores virales
|
|
JP5988961B2
(ja)
|
2010-04-28 |
2016-09-07 |
ザ ジェイ． デヴィッド グラッドストーン インスティテューツ |
心筋細胞を発生させるための方法
|
|
JP6208580B2
(ja)
|
2010-05-17 |
2017-10-04 |
サンガモ セラピューティクス， インコーポレイテッド |
新規のｄｎａ結合タンパク質及びその使用
|
|
HRP20171334T1
(hr)
|
2011-04-22 |
2017-11-17 |
The Regents Of The University Of California |
Virioni adeno-povezanog virusa s kapsid varijantom i postupci njihove upotrebe
|
|
WO2013033213A1
(en)
|
2011-08-30 |
2013-03-07 |
The J. David Gladstone Institutes |
Methods for generating cardiomyocytes
|
|
US9441206B2
(en)
|
2011-10-28 |
2016-09-13 |
The University Of North Carolina At Chapel Hill |
Cell line for production of adeno-associated virus
|
|
US9434928B2
(en)
|
2011-11-23 |
2016-09-06 |
Nationwide Children's Hospital, Inc. |
Recombinant adeno-associated virus delivery of alpha-sarcoglycan polynucleotides
|
|
ES2697249T3
(es)
|
2013-03-11 |
2019-01-22 |
Fond Telethon |
miR-204 y miR-211 y usos de los mismos
|
|
US9447433B2
(en)
|
2013-03-15 |
2016-09-20 |
The University Of North Carolina At Chapel Hill |
Synthetic adeno-associated virus inverted terminal repeats
|
|
JP6396988B2
(ja)
|
2013-03-15 |
2018-09-26 |
ザ・ユニヴァーシティ・オヴ・ノース・キャロライナ・アト・チャペル・ヒル |
二重グリカン結合性ａａｖベクターのための方法および組成物
|
|
US10604771B2
(en)
|
2013-05-10 |
2020-03-31 |
Sangamo Therapeutics, Inc. |
Delivery methods and compositions for nuclease-mediated genome engineering
|
|
EP3039129B1
(en)
|
2013-08-30 |
2018-06-27 |
Amgen Inc. |
High titer recombinant aav vector production in adherent and suspension cells
|
|
EP3043822A1
(en)
|
2013-09-11 |
2016-07-20 |
The J. David Gladstone Institutes, A Testamentary Trust Established under The Will of J. David Gladstone |
Compositions for preparing cardiomyocytes
|
|
EP3043866A4
(en)
|
2013-09-12 |
2017-05-17 |
President and Fellows of Harvard College |
Methods for inducing glucose uptake
|
|
WO2015042581A1
(en)
|
2013-09-23 |
2015-03-26 |
President And Fellows Of Harvard College |
Allele-specific rna silencing for the treatment of hypertrophic cardiomyopathy
|
|
US10144915B2
(en)
|
2013-10-23 |
2018-12-04 |
The J. David Gladstone Institutes, A Testamentary Trust Established Under The Will Of J. David Gladstone |
Reprogramming fibroblasts into cardiomyocytes
|
|
EP3099333B8
(en)
|
2014-01-31 |
2020-12-30 |
Temple University of the Commonwealth System of Higher Education |
Bag3 as a target for therapy of heart failure
|
|
GB201403684D0
(en)
|
2014-03-03 |
2014-04-16 |
King S College London |
Vector
|
|
US9287021B2
(en)
*
|
2014-03-04 |
2016-03-15 |
Whirlpool Corporation |
Shelf brackets to conduct electricity to refrigerator shelves
|
|
US11141493B2
(en)
|
2014-03-10 |
2021-10-12 |
Editas Medicine, Inc. |
Compositions and methods for treating CEP290-associated disease
|
|
DK3467111T3
(da)
|
2014-04-22 |
2022-03-14 |
Medizinische Hochschule Hannover |
LNCRNAS til terapi og diagnose af hjertehypertrofi
|
|
US10648000B2
(en)
|
2015-02-16 |
2020-05-12 |
University Of Florida Research Foundation, Incorporated |
rAAV vector compositions, methods for targeting vascular endothelial cells and use in treatment of type I diabetes
|
|
JP6836999B2
(ja)
|
2015-03-24 |
2021-03-03 |
ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニアＴｈｅ Ｒｅｇｅｎｔｓ Ｏｆ Ｔｈｅ Ｕｎｉｖｅｒｓｉｔｙ Ｏｆ Ｃａｌｉｆｏｒｎｉａ |
アデノ随伴ウイルス変異体及びその使用方法
|
|
JP6960396B2
(ja)
|
2015-04-07 |
2021-11-05 |
ザ ジェイ． デビッド グラッドストーン インスティテューツ、 ア テスタメンタリー トラスト エスタブリッシュド アンダー ザ ウィル オブ ジェイ． デビッド グラッドストーン |
分裂終了細胞の細胞分裂を誘発するための方法
|
|
EP3286318A2
(en)
|
2015-04-22 |
2018-02-28 |
Mina Therapeutics Limited |
Sarna compositions and methods of use
|
|
US20180296703A1
(en)
|
2015-08-17 |
2018-10-18 |
Temple University Of The Commonwealth System Of Higher Education |
Bag3 compositions and methods
|
|
CN108603176B
(zh)
|
2015-11-01 |
2022-10-21 |
格里科贝克有限责任公司 |
无病毒细胞系及获得其的方法
|
|
WO2017083750A1
(en)
|
2015-11-11 |
2017-05-18 |
Intrexon Corporation |
Compositions and methods for expression of multiple biologically active polypeptides from a single vector for treatment of cardiac conditions and other pathologies
|
|
EP3436569A4
(en)
|
2016-03-30 |
2019-11-13 |
The J. David Gladstone Institutes, A Testamentary Trust Established under The Will of J. David Gladstone |
ADVANCED DIRECT CARDIAL PROGRAMMING
|
|
WO2017181162A1
(en)
|
2016-04-16 |
2017-10-19 |
University Of Florida Research Foundation, Incorporated |
Methods of enhancing biological potency of baculovirus system-produced recombinant adeno-associated virus
|
|
EP3452101A2
(en)
|
2016-05-04 |
2019-03-13 |
CureVac AG |
Rna encoding a therapeutic protein
|
|
FI3445773T3
(fi)
*
|
2016-05-13 |
2023-03-30 |
4D Molecular Therapeutics Inc |
Adenoassosioituneen viruksen kapsidimuunnoksia ja niiden käyttömenetelmiä
|
|
WO2017201121A1
(en)
*
|
2016-05-17 |
2017-11-23 |
University Of Florida Research Foundation, Inc. |
Recombinant aav for gene therapy in lungs
|
|
WO2018005546A1
(en)
|
2016-06-27 |
2018-01-04 |
The J. David Gladstone Institutes, A Testamentary Trust Established Under The Will Of J. David Gladstone |
Engineered cardiomyocytes and uses thereof
|
|
US11566243B2
(en)
*
|
2016-07-18 |
2023-01-31 |
Jaan Biotherapeutics Llc |
Compositions and methods for treatment of cardiac diseases
|
|
CN109937258B
(zh)
|
2016-10-21 |
2023-06-23 |
味之素株式会社 |
蛋白质的分泌产生方法
|
|
US10550405B2
(en)
|
2017-03-15 |
2020-02-04 |
The University Of North Carolina At Chapel Hill |
Rational polyploid adeno-associated virus vectors and methods of making and using the same
|
|
WO2018222503A1
(en)
*
|
2017-05-31 |
2018-12-06 |
The Regents Of The University Of California |
Adeno-associated virus with variant capsid and methods of use thereof
|
|
CN107634856B
(zh)
|
2017-09-18 |
2020-12-22 |
金华市智甄通信设备有限公司 |
一种路由器固件升级方法及系统
|
|
US12186369B2
(en)
|
2017-09-20 |
2025-01-07 |
The Regents Of The University Of California |
Gene therapy strategy to restore electrical and cardiac function, and cardiac structure, in arrhythmogenic right ventricular cardiomyopathy
|
|
SG11202002276VA
(en)
|
2017-09-20 |
2020-04-29 |
4D Molecular Therapeutics Inc |
Adeno-associated virus variant capsids and methods of use thereof
|
|
US12098385B2
(en)
|
2017-09-20 |
2024-09-24 |
The Regents Of The University Of California |
Gene therapy strategy to restore cardiac electrical and structural function in arrhythmogenic right ventricular cardiomyopathy
|
|
CN112543766A
(zh)
|
2018-04-03 |
2021-03-23 |
斯特里迪比奥公司 |
抗体逃避性病毒载体
|
|
AU2019258830B2
(en)
|
2018-04-27 |
2025-12-18 |
Universität Heidelberg |
Modified AAV capsid polypeptides for treatment of muscular diseases
|
|
CA3111076A1
(en)
|
2018-08-30 |
2020-03-05 |
Tenaya Therapeutics, Inc. |
Cardiac cell reprogramming with myocardin and ascl1
|
|
US20220088052A1
(en)
|
2019-01-22 |
2022-03-24 |
Koninklijke Nederlandse Akademie Van Wetenschappen |
Tfap2 inhibition for treating cardiac disease involving fibro-fatty replacement
|
|
CA3134429A1
(en)
|
2019-03-28 |
2020-10-01 |
Esteve Pharmaceuticals, S.A. |
Methods for the manufacture of recombinant viral vectors
|
|
CN114450411A
(zh)
|
2019-04-01 |
2022-05-06 |
特纳亚治疗股份有限公司 |
具有工程化衣壳的腺相关病毒
|
|
EP3959226A2
(en)
|
2019-04-26 |
2022-03-02 |
Sangamo Therapeutics, Inc. |
Engineering aav
|
|
WO2020223279A1
(en)
|
2019-04-29 |
2020-11-05 |
Voyager Therapeutics, Inc. |
VECTORIZED ANTIBODIES (vAb) AND USES THEREOF
|
|
WO2020236982A1
(en)
|
2019-05-20 |
2020-11-26 |
The Broad Institute, Inc. |
Aav delivery of nucleobase editors
|
|
AU2020299026A1
(en)
|
2019-07-04 |
2022-01-20 |
Children's Medical Research Institute |
Methods and AAV vectors for in vivo transduction
|
|
RU2751592C2
(ru)
|
2019-08-22 |
2021-07-15 |
Общество С Ограниченной Ответственностью "Анабион" |
Выделенный модифицированный белок VP1 капсида аденоассоциированного вируса 5 серотипа (AAV5), капсид и вектор на его основе
|
|
WO2021041473A1
(en)
|
2019-08-27 |
2021-03-04 |
The Trustees Of Columbia University In The City Of New York |
Engineered exosomes for targeted delivery
|
|
KR20220066914A
(ko)
|
2019-09-20 |
2022-05-24 |
유씨엘 비즈니스 리미티드 |
부정맥 유발성 우심실 심근병증의 유전자 요법 조성물 및 치료
|
|
US20220403414A1
(en)
|
2019-10-16 |
2022-12-22 |
Wuxi Apptec (Shanghai) Co., Ltd. |
Novel aav variant
|
|
MX2022004771A
(es)
|
2019-10-22 |
2022-10-07 |
Applied Genetic Tech Corporation |
Vectores de virus adeno-asociados (aav) de triple funcion para el tratamiento de enfermedades asociadas a c9orf72.
|
|
CA3159964A1
(en)
|
2019-12-04 |
2021-06-10 |
Ac Immune Sa |
Novel molecules for therapy and diagnosis
|
|
AU2020408225A1
(en)
|
2019-12-20 |
2022-07-14 |
Research Institute At Nationwide Children's Hospital |
Optimized gene therapy for targeting muscle in muscle diseases
|
|
WO2021183825A1
(en)
|
2020-03-12 |
2021-09-16 |
California Institute Of Technology |
Adeno-associated viral capsids with expanded sizes
|
|
WO2021187380A1
(ja)
|
2020-03-16 |
2021-09-23 |
国立大学法人大阪大学 |
不整脈源性心筋症患者由来の多能性幹細胞およびその利用ならびに不整脈源性心筋症治療用医薬
|
|
CN116406297A
(zh)
|
2020-08-05 |
2023-07-07 |
阿斯克肋匹奥生物制药公司 |
治疗心脏疾患和充血性心力衰竭以及施用aav载体的方法
|
|
JP2023538519A
(ja)
|
2020-08-07 |
2023-09-08 |
スペースクラフト セブン リミテッド ライアビリティ カンパニー |
Ａａｖベクターを使用したプラコフィリン－２（ｐｋｐ２）遺伝子治療
|
|
EP3957650A1
(en)
|
2020-08-17 |
2022-02-23 |
Themis Bioscience GmbH |
Co-stimulatory 4-1bbl ectodomain polypeptides for immunomodulation
|
|
WO2022066898A2
(en)
|
2020-09-23 |
2022-03-31 |
Codiak Biosciences, Inc. |
Methods of producing extracellular vesicles
|
|
US11781156B2
(en)
|
2020-10-09 |
2023-10-10 |
Tenaya Therapeutics, Inc. |
Plakophillin-2 gene therapy methods and compositions
|
|
IL301675A
(en)
|
2020-10-09 |
2023-05-01 |
Tenaya Therapeutics Inc |
Methods and preparations for placophilin-2 gene therapy
|
|
IL301255A
(en)
|
2020-10-09 |
2023-05-01 |
UCB Biopharma SRL |
Nucleic acid structures, viral vectors and viral particles
|
|
WO2022079082A1
(en)
|
2020-10-15 |
2022-04-21 |
F. Hoffmann-La Roche Ag |
Nucleic acid constructs for simultaneous gene activation
|
|
WO2022098765A1
(en)
|
2020-11-03 |
2022-05-12 |
The Board Of Trustees Of The University Of Illinois |
Split prime editing platforms
|
|
KR20230127221A9
(ko)
|
2020-12-01 |
2024-12-06 |
로카나바이오 인크. |
Cag 반복 질환을 치료하기 위한 rna 표적화 조성물 및 방법
|
|
US20240108751A1
(en)
|
2020-12-01 |
2024-04-04 |
Locanabio, Inc. |
Rna-targeting compositions and methods for treating myotonic dystrophy type 1
|
|
TW202237850A
(zh)
|
2020-12-01 |
2022-10-01 |
賓州大學委員會 |
具有組織特異性靶向基序的新穎構成物及含有其之組成物
|
|
WO2022173847A2
(en)
|
2021-02-09 |
2022-08-18 |
Affinia Therapeutics Inc. |
Recombinant aavs with improved tropism and specificity
|
|
KR20230159471A
(ko)
|
2021-03-19 |
2023-11-21 |
유씨엘 비즈니스 리미티드 |
우심실 부정맥성 심근병증의 유전자 치료 조성물 및 치료
|
|
AU2022242086A1
(en)
|
2021-03-26 |
2023-10-19 |
Specific Biologics Inc. |
Targeting oncogentic mutations with dual-cleaving endonuclease
|
|
EP4320144A4
(en)
|
2021-04-05 |
2025-04-09 |
Janssen Biotech, Inc. |
T CELL RECEPTORS CALR AND JAK2
|
|
US20240173355A1
(en)
|
2021-04-05 |
2024-05-30 |
The Board Of Trustees Of The Leland Stanford Junior University |
Gene correction for rag2 deficiency in human stem cells
|
|
AR125406A1
(es)
|
2021-04-23 |
2023-07-12 |
Univ Pennsylvania |
Nuevas composiciones con motivos selectivos para el cerebro y composiciones que las contienen
|
|
WO2023200742A2
(en)
|
2022-04-11 |
2023-10-19 |
Tenaya Therapeutics, Inc. |
Capsids for plakophillin-2 gene therapy
|
|
TW202400798A
(zh)
|
2022-04-11 |
2024-01-01 |
美商特納亞治療股份有限公司 |
斑菲素蛋白—２（ｐｌａｋｏｐｈｉｌｌｉｎ—２）基因療法之治療方法
|